Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/3 trial evaluating neoadjuvant chemoradiation for borderline resectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: FOLFIRINOX + RT for Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating FOLFIRINOX combined with radiotherapy for pancreatic cancer; results date not provided in snippet.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects [Phase 2, Phase 3]
A pilot Phase 2/Phase 3 trial evaluated an epidermal growth factor ointment to manage EGFR-inhibitor–related skin side effects in cancer pat…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Study of SBP-101 in Pancreatic Cancer [Phase 1]
A Phase 1 study of SBP-101 in pancreatic cancer (ductal adenocarcinoma of the pancreas) conducted by Panbela Therapeutics has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of a modified nab-paclitaxel plus gemcitabine regimen for metastatic pancreatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: A Study for Participants With Pancreatic Cancer [Phase 1, Phase 2]
This update summarizes results from a Phase 1/2 clinical trial for pancreatic cancer sponsored by Eli Lilly; results were posted on 2018-04-…
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Molecularly Tailored Therapy for Pancreas Cancer [Phase 2]
Phase 2 clinical trial on molecularly tailored therapy for pancreatic cancer has completed. The update does not provide efficacy results in …
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Shark Mouth Modified Pancreaticojejunostomy
This entry provides a clinical trial update on a surgical technique called Shark Mouth Modified Pancreaticojejunostomy, sponsored by Peking …
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies [Phase 2]
A Phase 2 study evaluating ceritinib in ALK- and ROS1-activated gastrointestinal cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer
Completed clinical trial in Chinese patients evaluating a modified-FOLFIRINOX neoadjuvant regimen for locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer [NA]
The clinical trial evaluating Dignity Therapy/Life Plan for patients with pancreatic cancer and Non-Small-Cell Lung Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-15Clinical Trial Update: Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients [NA]
The clinical trial evaluating a Ketogen-based Therapeutic Diet for pancreaticobiliary cancer has completed, with Yonsei University as sponso…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients [NA]
Completed clinical trial investigating multi-tracer PET to predict and assess gemcitabine response in pancreatic cancer patients.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer
A completed clinical trial in metastatic pancreatic cancer analyzes how symptom outcomes and biomarkers relate to overall survival.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer [NA]
Clinical trial update on stereotactic body radiotherapy for unresectable pancreatic cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating carboplatin and paclitaxel with or without viral therapy in patients with recurrent or metastatic pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Improving Informed Consent for Palliative Chemotherapy [NA]
A completed trial evaluating improvements to informed consent for palliative chemotherapy in metastatic colorectal and pancreatic cancers.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating S-1 plus DC-CIK for unresectable locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. [Phase 3]
Phase 3 clinical trial update for Tarceva (erlotinib) plus gemcitabine in locally advanced/unresectable or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery [Phase 2]
Phase 2 trial evaluating dasatinib with gemcitabine hydrochloride or gemcitabine alone in previously surgically treated pancreatic cancer; s…
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer [Phase 1]
A Phase I trial of TH-302 (evofosfamide) in combination with gemcitabine and nab-paclitaxel for pancreatic cancer was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating bi-weekly gemcitabine plus nab-paclitaxel for metastatic pancreatic cancer was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and cetuximab in patients with advanced solid tumors across multiple cancer types; …
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating the combination of sorafenib, pemetrexed, and cisplatin in patients with advanced solid tumors; the study is comple…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial assessing the safety and dosing of the combination of bortezomib and gemcitabine in older patients with advanced solid tumor…